Details of the Drug

General Information of Drug (ID: DMEERGA)

Drug Name

MYK-224

Indication

Disease Entry	ICD 11	Status	REF
Obstructive hypertrophic cardiomyopathy	BC43.12	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05556343) A Phase 2a, Open-label, Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction (MERCUTIO). U.S.National Institutes of Health.